Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cells and is associated with SIRT1/FOXO1-related autophagy
PLOS One · 07.04.2026 · 21 (4) · e0346822
DOI: 10.1371/journal.pone.0346822 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 07.04.2026. Verfasst von Zhuxuan Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Sirtuin 1, Autophagy, Oxidative Stress, Metformin. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Special Project of ‘Cutting-Edge Biotechnology’ in the National Key Research and Development Program of China, Key Project Fund of National Natural Science Foundation, the Regional Innovation and Development Joint Fund of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Metformin (MET), a first-line antidiabetic drug, has been increasingly implicated in cellular protection under oxidative stress, yet its mechanisms in lens epithelial cells (LECs) remain incompletely defined. Using a tert-butyl hydroperoxide (TBHP)-induced acute oxidative injury model in human HLE-B3 cells, we investigated whether SIRT1/FOXO1-related autophagy contributes to MET-associated cytoprotection. MET pretreatment reduced intracellular reactive oxygen species, preserved antioxidant defenses, improved cell viability, and decreased apoptosis after TBHP challenge. MET also enhanced autophagy markers and, under lysosomal blockade with chloroquine or bafilomycin A1, showed LC3-II/p62 changes consistent with increased autophagic flux. Pharmacologic inhibition of SIRT1 (EX-527) or early-stage autophagy (3-methyladenine) partially attenuated MET-associated improvements across oxidative stress and survival endpoints, supporting a role for SIRT1/FOXO1-related autophagy in this response. Although limited to an in vitro setting and pharmacological perturbation, these findings suggest that MET may mitigate oxidative injury in lens epithelium, highlighting SIRT1/FOXO1-autophagy as a potential pathway relevant to oxidative stress processes in cataractogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China.
- Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
- Lanzhou Huaxia Eye Hospital, Lanzhou, Gansu, China.
ORCID-Profile: Wei Chi, Zhenguo Yan
Förderung
- the Key Special Project of ‘Cutting-Edge Biotechnology’ in the National Key Research and Development Program of China
- Key Project Fund of National Natural Science Foundation
- the Regional Innovation and Development Joint Fund of the National Natural Science Foundation of China
- Sanming Project of Medicine in Shenzen Municipality
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Yan, Z., Chi, W., Yan, Z., & Wang, H. (2026). Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cells and is associated with SIRT1/FOXO1-related autophagy. PLOS One, 21(4), e0346822. https://doi.org/10.1371/journal.pone.0346822
Vancouver
Yan Z, Chi W, Yan Z, Wang H. Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cells and is associated with SIRT1/FOXO1-related autophagy. PLOS One. 2026;21(4):e0346822. doi:10.1371/journal.pone.0346822
BibTeX
@article{Yan2026,
author = {Yan, Zhuxuan and Chi, Wei and Yan, Zhenguo and Wang, Hanrui},
title = {Metformin attenuates TBHP-induced oxidative injury in human lens epithelial cells and is associated with SIRT1/FOXO1-related autophagy},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0346822},
doi = {10.1371/journal.pone.0346822}
}
EUVIMED